Combined with the discovery that circ-ERBB2 was localized in the cytoplasm, we continued to investigate whether circ-ERBB2 exerted a regulatory function in HER2-positive breast cancer through the competing endogenous RNA (ceRNA) mechanism. This evidence concerns the gene ERBB2 and breast cancer.